SPEU.US State Street SPDR Portfolio Europe ETF
- Total assets
- 717M
- Expense ratio
- 0.07%
- Dividend yield
- 3.58%
- 1-year return
- +10.60%
- Holdings
- 1,675
- Since
- 2002
Fund data as reported by the issuer, updated Nov 18, 2026. Total assets are in the fund's base currency.
What does SPEU.US invest in?
- Mostly Non-US stocks (102.2%)
- Largest sector: Financial Services (24.1%)
- Largest region: Europe Developed (77.0%)
- Top 3 holdings: 7.4% of the fund
Asset allocation
- Non-US stocks 102.2%
- US stocks 1.1%
- Other 0.2%
- Cash 0.2%
- Not classified 0.0%
Top holdings
- ASML Holding N.V. 3.37%
- Roche Holding AG 2.05%
- HSBC Holdings PLC 1.97%
- Novartis AG 1.82%
- AstraZeneca PLC 1.78%
State Street SPDR Portfolio Europe ETF performance
Sharpe ratio 1.05- This year
- +7.63%
- 1 year
- +10.60%
- 3 years
- +18.26%
- 5 years
- +8.41%
Volatility 15.3% over 1 year and 13.7% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
SPEU.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About State Street SPDR Portfolio Europe ETF
Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. It employs a sampling strategy, which means that the fund is not required to purchase all of the securities represented in the index. The index is a free-float market capitalization weighted index designed to provide a broad representation of publicly traded Western European companies.
Full fund profileState Street SPDR Portfolio Europe ETF top holdings
18.5% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| ASML Holding N.V. ASML.AS | Technology | Netherlands | 3.37% |
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 2.05% |
| HSBC Holdings PLC HSBA.LSE | Financial Services | United Kingdom | 1.97% |
| Novartis AG NOVN.SW | Healthcare | Switzerland | 1.82% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 1.78% |
| Shell plc SHEL.LSE | Energy | United Kingdom | 1.72% |
| Nestle S.A. NESN.SW | Consumer Defensive | Switzerland | 1.63% |
| SAP SE SAP.XETRA | Technology | Germany | 1.45% |
| Siemens Aktiengesellschaft SIE.XETRA | Industrials | Germany | 1.44% |
| TotalEnergies SE ADR TTE.US | Energy | United States | 1.23% |
The 10 largest of 1,675 holdings.
SPEU.US sector exposure
- Financial Services24.1%
- Industrials18.8%
- Healthcare13.7%
- Consumer Defensive8.6%
- Technology8.5%
- Consumer Cyclicals7.1%
- Basic Materials5.8%
- Energy5.3%
- Utilities4.5%
- Communication Services2.8%
- Real Estate1.4%
Share of the stocks in the fund.
SPEU.US regional exposure
- Europe Developed77.0%
- United Kingdom22.0%
- North America1.2%
- Europe Emerging1.2%
- Asia Developed0.4%
- Latin America0.0%
- Africa/Middle East0.0%
- Asia Emerging0.0%
Share of the stocks in the fund.
Company size
Average market cap 58.3B- Mega cap49.1%
- Big cap31.5%
- Medium cap15.5%
- Small cap4.0%
- Micro cap0.6%
State Street SPDR Portfolio Europe ETF fund profile
- Fund name
- State Street SPDR Portfolio Europe ETF
- Ticker
- SPEU.US
- Exchange
- USA Stocks
- Issuer
- State Street Investment Management
- Index tracked
- -
- Category
- Europe Equity
- Inception date
- Oct 15, 2002
- Trading currency
- USD
- Expense ratio
- 0.07%
- Annual turnover
- 0.1%
About State Street SPDR Portfolio Europe ETF
Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. It employs a sampling strategy, which means that the fund is not required to purchase all of the securities represented in the index. The index is a free-float market capitalization weighted index designed to provide a broad representation of publicly traded Western European companies.